VDAC1 and malignant mesothelioma: Expression levels of VDAC1 in samples from healthy individuals and patients with malignant mesothelioma were assessed in a tissue microarray slide by immunohistochemistry (IHC) using VDAC1-specific antibodies (Figure 1A,B).